Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Achieve Life Sciences Inc ACHV

Achieve Life Sciences, Inc. is a late-stage clinical pharmaceutical company. The Company is engaged in development and commercialization of cytisinicline for smoking cessation and nicotine addiction. The Company’s product candidate, cytisinicline, is a naturally occurring, plant-based alkaloid. Cytisinicline is structurally similar to nicotine and has a well-defined, dual-acting mechanism of... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:ACHV)

Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine

GlobeNewswire 4 hours ago

Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV

Accesswire 7 days ago

Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024

GlobeNewswire 11 days ago

Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference

GlobeNewswire April 11, 2024

Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update

GlobeNewswire March 28, 2024

Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting

GlobeNewswire March 20, 2024

Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024

GlobeNewswire March 14, 2024

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

GlobeNewswire March 6, 2024

Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission

GlobeNewswire February 29, 2024

Opinion & Analysis (NDAQ:ACHV)

No current opinion is available.

Bullboard Posts (NDAQ:ACHV)

new site with deep DD on ACHV 👇

New site with Deep DD on ACHV: FrugalNorwegian.com - All information on 1 page - Catalyst countdown timer - Several videos to watch...
FrugalNorwegian - May 7, 2021

it's a sell today for me

will use this one for tax loss selling,this one didn't work out for me,so glta.
coolfooldumbguy - December 19, 2019

it's a buy today for me

at $1.15 per share,breaking out this morning,so glta.
coolfooldumbguy - December 17, 2019

Achieve Life Sciences

Just wondering if ACHV could go to $5 next week?
rubadub - February 22, 2019